На главную
Результаты поиска “Memorial sloan kettering papillary thyroid cancer”
Lymph Nodes in Thyroid Cancer -- Sloan-Kettering
 
04:47
Unlike in many other cancers, the spread of thyroid cancer to the lymph nodes has very little impact on survival in most patients, say thyroid cancer experts at Memorial Sloan-Kettering Cancer Center. Lymph nodes that look suspicious may be removed during thyroid surgery, but in most cases, this does not affect the outcome of treatment. For more information, please visit http://www.mskcc.org/thyroidcancer
Просмотров: 7559 Memorial Sloan Kettering
Experts Discuss Thyroid Cancer Questions | Memorial Sloan Kettering
 
23:32
For more information on thyroid cancer, please visit http://www.mskcc.org/thyroidcancer Like us on Facebook: http://www.facebook.com/sloankettering Follow us on Twitter: http://twitter.com/sloan_kettering Physicians at Memorial Sloan Kettering Cancer Center answer a variety of questions such as risk factors for thyroid cancer, frequency of locally recurrent disease after initial treatment, the importance of experience in using and interpreting imaging data, side effects of radioactive iodine, clinical trials for thyroid cancers that do not respond to radioactive iodine, and the shift toward individualized treatment. {partial transcript} This is a very active area of investigation that has really seen the fruits of its labor over the past five to ten years. Even with more aggressive cancer, there are a lot of reasons to be optimistic? There is much more hope now than there was ten years ago. You talked a bit about before about folks of a certain age receiving radiation therapy for tumors that turned out to be benign. For instance, in children, the thymus gland was enlarged and it turned out to be normally enlarged. Unfortunately, we thought that was bad and a certain population of people ended up with thyroid cancer, secondary to their radiation therapy. Can we talk about risk factors for thyroid cancer and if there’s anything that we can do to avoid some of these risk factors? I’m not sure about how to avoid it, but regarding radiation, there is quite a bit of radiation from the diagnostic imaging in our general population….
Просмотров: 14765 Memorial Sloan Kettering
Management and Follow-up of High Risk Patients with Papillary Thyroid Cancer
 
34:20
Management and Follow-up of High Risk Patients with Papillary Thyroid Cancer -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA *** מוגש כשירות לציבור הגולשים והגולשות בלבד ואינו מהווה תחליף כלשהו לייעוץ רפואי אישי ופרטני ***
Просмотров: 2311 Rambam Pro
Advances in Thyroid Cancer Treatment -- Sloan-Kettering
 
17:20
Memorial Sloan-Kettering Cancer Center specialists in endocrinology, surgery, and radiology discuss the latest approaches to diagnosing and treating thyroid cancer, and reducing the risk of recurrence. For more information, please visit http://www.mskcc.org/thyroidcancer.
Просмотров: 7252 Memorial Sloan Kettering
Lymph Nodes in Thyroid Cancer
 
04:47
Experts from MSKCC say that removing suspicious lymph nodes during thyroid cancer surgery may not affect treatment outcomes for most patients.
Просмотров: 1845 Memorial Sloan Kettering
Staging Thyroid Cancer and Residual Disease -- Sloan-Kettering
 
07:59
Diagnostic tools have become so sensitive that they can detect even the tiniest amount of thyroid cancer cells that remain after treatment. But just because doctors find some thyroid cancer cells does not always mean that additional treatment is necessary, say specialists at Memorial Sloan-Kettering Cancer Center, because they may not pose a significant threat to a patient's health. The side effects and costs of treatment must be considered carefully before treating these residual tumors. For more information, please visit http://www.mskcc.org/thyroidcancer
Просмотров: 4424 Memorial Sloan Kettering
The basics of thyroid cancer - Penn State Hershey Cancer Institute
 
04:55
David Goldenberg, M.D., discusses the various types of thyroid cancer, how they're detected, how they're treated -- and how the prognosis can vary depending on the type. Dr. Goldenberg is director of head and neck surgery at Penn State Hershey Medical Center.
Просмотров: 7024 PennStateHershey
Small Thyroid Cancers, Thyroid Hormones, and More.
 
11:47
In this 12-minute video interview, R. Michael Tuttle, M.D., Endocrinologist at Memorial Sloan-Kettering Cancer Center in New York, New York, discusses several thyroid cancer topics. These include recent research on “watchful waiting” (also called active surveillance) rather than immediate surgery for small papillary or follicular thyroid cancers —under 1 centimeter in size. The interview also covers thyroid hormone replacement decision-making in thyroid cancer patients, as well as the issues of overdiagnosis and overtreatment. Dr. Tuttle is a thyroid cancer specialist, focusing on treatment of advanced thyroid cancer. He is a ThyCa Medical Advisor.
Diagnosing Thyroid Cancer -- Sloan-Kettering
 
03:28
Radiologist Lucy Hann of Memorial Sloan-Kettering Cancer Center explains how ultrasound is used to determine whether a thyroid tumor is benign (noncancerous) or malignant (cancerous). Features such as the amount of calcification or fluid a tumor contains can help doctors determine whether a patient requires a biopsy or surgery. For more information, please visit http://www.mskcc.org/thyroidcancer
Просмотров: 1396 Memorial Sloan Kettering
Bellas Story: Thyroid Cancer
 
03:28
This is for my bio project on thyroid cancer, and i got my friend Bella to talk about what its like to have thyroid cancer. Credit to Mattia Cupelli for the song
Просмотров: 6312 Buffy OnTheStreet
12-3 - Jatin P Shah -  Treatment for Differentiated Cancer (Part 3)
 
10:29
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Просмотров: 12739 StatementsCancer
Panel Discussion: Surgical Treatment for Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD (ENT)
 
21:00
Panel Discussion: Surgical Treatment for Papillary Thyroid Cancer Moderator: Ziv Gil, MD, PhD Chairman, Department of Otolaryngology, Rambam HCC, Haifa -- Gideon Bachar, MD Department of Otolaryngology, Rabin Medical Center, Petah Tikva -- Diana Gaitini, MD Director, Ultrasound Unit, Department of Medical Imaging, Rambam HCC, Haifa -- Haitam Nasrallah, MD Institute of Oncology, Rambam HCC, Haifa -- Moshe Shabtai, MD Vice Chairman, Department of Surgery, Head Endocrine Surgery Service, The Chaim Sheba Medical Center, Tel-Hashomer -- R Michael Tuttle, MD Professor of Medicine, Endocrinology Service, Memorial Sloan Kettering Cancer Center, Cornell University, New York, NY, USA *** מוגש כשירות לציבור הגולשים והגולשות בלבד ואינו מהווה תחליף כלשהו לייעוץ רפואי אישי ופרטני ***
Просмотров: 1265 Rambam Pro
RAI and Nuclear Medicine in Thyroid Cancer.
 
22:16
In this 22-minute video, Douglas Van Nostrand, M.D., Director of Nuclear Medicine at MedStar Washington Hospital Center, explains the following topics: how radioactive iodine works, consulting with patients seeking second opinions, getting patients' questions answered, and more topics. Dr. Van Nostrand's focus is thyroid cancer, primarily papillary and follicular thyroid cancer. He is widely published in the field of nuclear medicine and is on the Editorial Review Board for the Society of Nuclear Medicine and Molecular Imaging. He is a co-author and co-editor of reference books for patients and medical professionals and has spoken at numerous professionals’ and ThyCa events. He is a ThyCa Medical Advisor.
Screening Not Recommended for Thyroid Cancer
 
00:47
Learn about Thyroid Cancer: https://www.mskcc.org/cancer-care/types/thyroid CONNECT WITH MSK Facebook: http://facebook.com/sloankettering Twitter: http://twitter.com/sloan_kettering Instagram: http://instagram.com/sloankettering Request an appointment at MSK by calling 800-525-2225 or online at: https://www.mskcc.org/appointments/request-appointment
Просмотров: 115 Memorial Sloan Kettering
12-1 - Jatin P Shah -  Treatment for Differentiated Cancer (Part 1)
 
15:01
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Просмотров: 6399 StatementsCancer
12-2 - Jatin P Shah - Treatment for Differentiated Cancer (Part 2)
 
14:51
1 Treatment for Differentiated Thyroid Gland Cancer 2 Thyroid Cancer: Issues 3 Incidence and Mortality US 4 Differentiated Cancer of the Thyroid Gland 5 Pathology 6 Prognosis 7 Exploiting Biology for Management 8 Prognosis in Thyroid Cancer 9 Genetic Progression in Papillary Cancers 10 Clinical parameters in management 11 Differentiated Cancer of the Thyroid Gland 12 Thyroid Cancer: Source of Data 13 Papillary Cancer: Surgical treatment 14 Follicular Cancer: Surgical treatment 15 Papillary Relative Survival 16 Survival at 5 Years vs Type of Surgical Treatment 17 Prognosis: Parameters to rely on 18 Prognostic Factors 19 Prognostic factors: 20-Year Survival 20 Risk stratification of patients 21 Selection of Therapy 22 Lobectomy vs Total Thyroidectomy 23 Thyroid Carcinoma with Extrathyroid Extension 24 Surgery for Extrathyroid Extension 25 Invasion of Recurrent Laryngeal Nerve 26 Invasion of the Trachea 27 Video: Total Thyroidectomy, Trachea Resection 28 Case Examples 29 Extrathyroid Extension: Esophagus 30 Case Examples 31 Patterns of Neck Metastases 32 Central Compartment Node Dissection 33 Modified Radical ND, Case Examples 34 Differentiated Cancer of the Thyroid: Follow up 35 Low Risk Thyroid Cancer: Data Mayo Clinic 36 Problems with the Current Follow Up Regimen 37 Genetic Progression Model 38 Molecular Factors in Thyroid Cancer 39 Summary
Просмотров: 3785 StatementsCancer
Learn about our approach to thyroid cancer care.
 
02:44
Meet our thyroid cancer specialists and learn about our approach to care. Learn about Thyroid Cancer: https://www.mskcc.org/cancer-care/types/thyroid CONNECT WITH MSK Facebook: http://facebook.com/sloankettering Twitter: http://twitter.com/sloan_kettering Instagram: http://instagram.com/sloankettering Request an appointment at MSK by calling 800-525-2225 or online at: https://www.mskcc.org/appointments/request-appointment
Просмотров: 147 Memorial Sloan Kettering
Biopsies and Novel Therapies for Thyroid Cancer -- Sloan-Kettering
 
04:31
Radiologist Lucy Hann describes a quick and relatively painless procedure called fine-needle biopsy, which is used to extract thyroid tumor cells for analysis under a microscope. Endocrinologist Michael Tuttle describes new drugs currently in clinical trials that have improved the ability to treat patients with aggressive tumors that are resistant to radioactive iodine therapy. For more information, please visit http://www.mskcc.org/thyroidcancer
Просмотров: 593 Memorial Sloan Kettering
My experience with thyroid cancer
 
06:36
This video explains my thoughts about thyroid cancer. It also explains my experience with my surgeries.
Просмотров: 51575 ooshkey
Endoscopic total thyroidectomy with node dissection for papillary thyroid cancer
 
08:21
This video demonstrates the technique of total thyroid excision with lymph node removal for papillary thyroid cancer.
Просмотров: 53206 MountSinaiMEMIS
Thyroid Cancer | Dr. Tony Talebi Discusses the Treatment of Papillary Thyroid Cancer
 
50:20
Dr Tony Talebi discusses the treatment of papillary thyroid cancer with Dr. Kim, Assistant professor of medicine at University of Miami and director of thyroid diseases. Dr Talebi is the owner of Miami Hematology and Oncology Associates.
Просмотров: 9751 Tony Talebi
Staging Thyroid Cancer and Residual Disease
 
07:59
MSKCC thyroid cancer experts say that additional treatment may not be needed for residual tumors that do not pose a threat to a patient’s health.
Просмотров: 151 Memorial Sloan Kettering
Case Study: Treating Papillary Thyroid Cancer
 
05:12
Marcia S. Brose, MD, PhD, presents a case study focused on a women diagnosed with papillary thyroid cancer at age 35 who went on to receive systemic therapy. For more from this discussion, visit http://www.onclive.com/peer-exchange/thyroid-cancer
Просмотров: 2780 OncLiveTV
Mechanism-based Therapies for Advanced Thyroid Cancers
 
51:50
A Division of Endocrinology, Diabetes and Bone Diseases Grand Rounds presented by James A. Fagin, MD, Memorial Sloan Kettering Cancer Center
Просмотров: 66 Icahn School of Medicine
Thyroid Cancer Natural Cure Ttreatment
 
07:03
Просмотров: 14742 NutritionPHD
Thyroid Cancer Video Diary #1-After Surgery
 
03:10
Просмотров: 4847 LMotte12
Dr. Sherman on Pazopanib in Anaplastic Thyroid Cancer
 
02:20
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses the treatment of anaplastic thyroid cancer with intensity-modulated radiation therapy (IMRT), paclitaxel, and pazopanib. For more on head and neck cancer: http://www.onclive.com/specialty/head-and-neck
Просмотров: 810 OncLiveTV
Papillary Thyroid Cancer - Post3
 
01:51
My Journey through diagnosis, treatment and comeback :)
Просмотров: 905 MyCancerJournal
Living With Thyroid Cancer: After Surgery Follow-up Care
 
04:02
Surgeons, doctors and professionals discuss the many aspects of thyroid surgery aftercare, including who is involved (it's not just the surgeons!), what to expect as far as after-surgery symptoms to watch for and activities to avoid, and their own personal theories on aftercare best practices. Featuring: David Myssiorek, MD (New York University School of Medicine), R. Michael Tuttle, MD (Memorial Sloan Kettering), Joshua Klopper, MD (University of Colorado).
Просмотров: 3367 Vital Options International
papillary thyroid cancer - post 1
 
06:45
My journey through papillary thyroid cancer diagnosis, treatment and recovery to help others in similar situations
Просмотров: 4302 MyCancerJournal
Papillary and Follicular Thyroid Cancer. When and How To Treat, or Watch and Wait. Dr. Busaidy.
 
59:14
Papillary and Follicular Thyroid Cancer. When and How To Treat, or Watch and Wait. Dr. Busaidy. ThyCa Conference. Naifa L. Busaidy, M.D., Endocrinologist
Dr. Sherman on Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
 
01:30
Eric J. Sherman, MD, Head and Neck Oncology Service, Memorial Sloan-Kettering Cancer Center, discusses a pilot study of selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. More on head and neck cancer: http://www.onclive.com/specialty/head-and-neck
Просмотров: 238 OncLiveTV
Anaplastic Thyroid Cancer Sosa and Tuttle 07292011
 
01:03:42
Published on Jul 27, 2014 Anaplastic Thyroid Cancer Recorded July 29, 2011 Speakers: Julie Ann Sosa, M.D., M.A. and R. Michael Tuttle, M.D. Julie Ann Sosa, M.D., M.A., is an Endocrine and Oncologic Surgeon and Associate Professor of Surgery at Yale University School of Medicine, New Haven, Connecticut. She is principal investigator or co-principal investigator of studies of new drug treatments for differentiated thyroid cancer (papillary/follicular), medullary thyroid cancer, and anaplastic thyroid cancer. Following undergraduate education at Princeton University, she received a master's degree in Human Sciences at the University of Oxford in the United Kingdom and her medical degree from Johns Hopkins University School of Medicine, Baltimore, Maryland. She received postgraduate training at Johns Hopkins Hospital in Baltimore, Maryland, as well as John Radcliffe and Churchill Hospitals, Oxford, England. She is a frequent invited lecturer and course leader/instructor for professional audiences. She is a member of ThyCa”s Medical Advisory Council. R. Michael Tuttle, M.D. is an endocrinologist at Memorial Sloan-Kettering Cancer Center, New York, New York. He is also Professor of Medicine at the Joan and Sanford I. Weill Medical College of Cornell University in New York, NY. He is an active clinician and researcher specializing in the management of advanced thyroid cancer. He travels extensively both within the US and abroad lecturing on the difficult management issues in thyroid cancer. His research projects in radiation-induced thyroid cancer have taken him from Kwajalein Atoll in the Marshall Islands to the Hanford Nuclear power-plant in Washington State to regions in Russia that were exposed to fallout from the Chernobyl accident. He serves on the American Thyroid Association committee that produced the current guidelines for the management of benign and malignant thyroid nodules. He also chaired the National Comprehensive Cancer Network Thyroid Cancer Panel, and served on the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug, and as a consultant. He is a member of ThyCa”s Medical Advisory Council. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa's web site. She also represents ThyCa at medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Dr. Tuttle on Augmenting Pre-Operative Risk of Recurrence Stratification in DTC
 
01:38
R. Michael Tuttle, MD, Memorial Sloan Kettering Cancer Center, discusses a study that looked at augmenting pre-Operative risk of recurrence stratification in differentiated thyroid carcinoma. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Просмотров: 413 Targeted Oncology
Thyroid Cancer Patient Stories
 
01:45
Butterfly Thyroid Cancer Trust is the first charity in the UK to be dedicated solely to the support of patients with thyroid cancer. This short clip provides a brief insight into the experiences of Papillary Thyroid Carcinoma survivors, and is part of a forthcoming thyroid cancer film to be distributed free to all new thyroid cancer patients in the UK. http://www.butterfly.org.uk http://www.euanpreston.com
Просмотров: 11249 ButterflyTCT
Thyroid Cancer: NOT the Good Cancer
 
04:47
Thyroid Cancer is NOT the "good cancer." Compiled by Nikki Ferraro, thyroid cancer survivor and founder of Bite Me Cancer www.bitemecancer.org
Просмотров: 37030 Bite Me Cancer
Thyroid Cancer
 
06:56
My papillary thyroid cancer story. Summed up.
Просмотров: 3484 Cody Noble
Dr. R. Michael Tuttle on New Horizons for Radioactive Iodine Treatment
 
01:37
R. Michael Tuttle, MD, professor of Medicine, Memorial Sloan Kettering Cancer Center talks about the new horizons for radioactive iodine treatment in thyroid cancer. He says some new treatments, like the MAP kinase inhibitor and BRAF inhibitor, block pathways that would allow a cancerous thyroid tumor to concentrate radio iodine. For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Просмотров: 370 Targeted Oncology
Living with Thyroid Cancer: Lori's Story
 
05:47
Lori has been living with thyroid cancer since 2008. In this video she talks about the things that have helped her through her diagnosis along with the many treatments she has undergone. This is an inspiring story of a person's struggle to come to terms with cancer. http://www.streamingwell.com/thyroid-cancer-loris-story-video.html Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe. Find us at: http://www.streamingwell.com Subscribe to Streaming Well: http://www.youtube.com/subscription_center?add_user=StreamingWell Like us on: http://www.facebook.com/StreamingWell Follow us on: http://www.twitter.com/StreamingWell Follow us on: http://www.instagram.com/streamingwell Follow us on: http://pinterest.com/StreamingWell/
Просмотров: 24281 streamingwell
Papillary Thyroid Cancer | Symptoms, Treatments, and Prognosis for Papillary Thyroid Cancer
 
01:18
Papillary Thyroid Cancer | Symptoms, Treatments, and Prognosis for Papillary Thyroid Carcinoma, all about Papillary Thyroid Cancer. VISIT: ►►► http://Papillary-ThyroidCancer.com ◄◄◄ http://www.youtube.com/watch?v=eVM4Vs47IW0 Papillary thyroid cancer (also sometimes called papillary thyroid carcinoma) is the most common type of thyroid cancer. You may have even heard your doctor talk about metastatic papillary thyroid cancer ("metastatic" means that it has spread beyond your thyroid gland). This article will focus on papillary thyroid cancer basics, including papillary thyroid cancer symptoms, treatments, and prognosis Papillary thyroid carcinoma is the most common thyroid cancer. About 80% of all thyroid cancers cases are papillary thyroid cancer.1 What are some papillary thyroid cancer signs and symptoms? Papillary carcinoma typically arises as an irregular, solid or cystic mass that comes from otherwise normal thyroid tissue. This cancer has a high cure rate with 10-year survival rates for all patients with papillary thyroid cancer estimated at 80% to 90%. Cervical metastasis (spread to lymph nodes in the neck) are present in 50% of small papillary carcinomas and in more than 75% of the larger papillary thyroid carcinomas. The presence of lymph node metastasis in these cervical areas causes a higher recurrence rate but not a higher mortality rate. Distant metastasis is uncommon, but lung and bone are the most common sites if the papillary carcinoma does spread. Tumors that invade or extend beyond the thyroid capsule have a much worse prognosis because of a high local recurrence rate. But what do doctors look for to diagnose papillary thyroid cancer? Characteristics of Papillary Thyroid Cancer Peak onset ages are 30 to 50 years old. Papillary thyroid cancer is more common in females than in males by a 3:1 ratio. The prognosis directly related to tumor size. (Less than 1.5 cm [1/2 inch] is a good prognosis.) This cancer accounts for 85% of thyroid cancers due to radiation exposure. In more than 50% of cases, it spreads to lymph nodes of the neck. Distant spread (to lungs or bones) is uncommon. The overall cure rate is very high (near 100% for small lesions in young patients). Although survival following papillary thyroid cancer (PTC) is high, a small but significant number of recurrences and deaths occur decades after diagnosis, a long-term study has found. The 3 most commonly cited studies on PTC have median follow-up times of 11, 15, and 15.7 years. In contrast, the new research reports on a median of 27 years of follow-up in a cohort of 269 PTC patients, said Raymon H. Grogan, MD, assistant professor of surgery and director of the endocrine surgery research program at the University of Chicago Medicine, Illinois. He presented the findings this week here at the American Association of Endocrine Surgeons 2013 Annual Meeting. Papillary thyroid cancer (as is the case with follicular thyroid cancer) typically occurs in the middle aged with a peak incidence in the 3rd and 4th decades. It is more common in women with a F:M ratio of 1:1.6 - 3:1 2. Papillary thyroid cancer, which is the most common type of thyroid cancer, makes up about 80% of all cases of thyroid cancer. It is one of the fastest growing cancer types with over 20,000 new cases a year. In fact, it is the 8th most common cancer among women overall and the most common cancer in women younger than 25. Most Patients Survive Papillary Thyroid Cancer Regardless of Treatment According to a study reported on in the May, 2010 issue of the Archives of Otolaryngology-Head & Neck Surgery, papillary thyroid cancer that has not spread outside the thyroid gland has a generally favorable outcome for patients, whether or not they receive treatment within a year of diagnosis. According to the study author, "...nearly every thyroid gland might be found to have a cancer if examined closely enough. The advent of ultrasonography and fine-needle aspiration biopsy has allowed many previously undetected cancers to be identified, changing the epidemiology of the disease. Over the past 30 years, the detected incidence of thyroid cancer has increased three-fold, the entire increase attributable to papillary thyroid cancer and 87% of the increase attributable to tumors measuring less than 2 centimeters." Although survival following papillary thyroid cancer (PTC) is high, a small but significant number of recurrences and deaths occur decades after diagnosis, a long-term study has found. "Papillary thyroid cancer in general has a very good prognosis... Also, papillary thyroid cancer rates have been rising steadily for several decades worldwide. The combination of these 2 factors means that more and more people will be living with [the diagnosis] for several decades. This is why we think our study is important," Dr. Grogan told Medscape Medical News. Papillary Thyroid Cancer http://www.youtube.com/PapillaryThyroidCanc . .
Просмотров: 15700 Papillary Thyroid Cancer
Thyroid Cancer Diagnosis
 
01:55
(KUTV) Experts say more cases of thyroid cancer are being diagnosed in the United States.The first symptom is what is called a thyroid nodule. Generally when tests come back inconclusive, doctors have a tough choice to make.Six weeks after giving birth doctors discovered that Aimee Ferrell had a thyroid nodule, which can be a symptom of cancer. Results from a biopsy were inconclusive, traditionally at this stage doctors will perform surgery to remove the thyroid for further testing.Doctor Shahzad Ahmad is a physician at the Thyroid Institute of Utah, instead of performing surgery on patients who have inconclusive thyroid biopsy results, he orders a genome test. In Aimme's case the genome test showed no signs of cancer, she will be tested every 6 months just to make sure no cancerous cells are developing.Doctor Ahmad says about 15 to 30 percent of biopsy results for thyroid cancer come back inconclusive, if doctors perform surgery the patient will need to be on medication for the rest of his or her life.(Copyright 2013 Sinclair Broadcasting Group)
Просмотров: 8436 KUTV2News
Thyroid Cancers Less Likely To Shorten Lifespan
 
01:44
The word cancer surely strikes fear in anyone who gets that diagnosis. But more and more often researchers are finding many forms of disease are survivable and livable. More than 56,000 Americans will be diagnosed with thyroid cancer this year. And new research gives them new reason to be hopeful. "Unlike some other cancers, say breast cancer, stomach cancer, even ovarian cancer, thyroid cancer, 95 percent of the time, is a very slow growing, very controllable situation," says Dr. Jacob Golderberger, a general surgeon on the medical staff of Lee Memorial Health System. In fact, most people with thyroid cancer will live as long as people who don't have the disease, provided they get proper treatment. "The nice thing about the thyroid growth, even if it is cancer, it's not a very aggressive cancer. And the success rate in treating that is pretty high. It's an 80 to 90 percent cure rate with the surgery," says Dr. Golderberger. Doctors document nodules with ultrasound and biopsy suspicious growths to determine whether it's cancerous. The majority of thyroid cancers are benign. "It's the malignant ones that we have to deal with a more radical approach, and that is you have to remove the whole thyroid. That's a standard of care and you are left with no thyroid at all," says Dr. Golderberger. People can live without a thyroid, but not the thyroid hormone. It's required to manage our metabolism. Without it, patients are dependent on hormone therapy but can still enjoy a good quality of life. "I would say, close to one third of all people in this country are on some kind of a thyroid replacement," says Dr. Golderberger. Only patients with advanced cases, where the cancer had spread to other parts of the body, had a lower chance of long-term survival than the general population. Today improved diagnostics and treatment is making thyroid cancer a livable disease. View More Health Matters video segments at leememorial.org/healthmatters/ Lee Memorial Health System in Fort Myers, FL is the largest network of medical care facilities in Southwest Florida and is highly respected for its expertise, innovation and quality of care. For nearly a century, we've been providing our community with everything from primary care treatment to highly specialized care services and robotic assisted surgeries. Visit leememorial.org
Просмотров: 1235 Lee Health
Thyroid Cancer
 
55:47
Diana McNeill, MD Ramon M. Esclamado, MD
Просмотров: 2458 Duke Clinical Research Institute
Thyrogen used in connection with testing and treatment of differentiated thyroid cancer
 
58:49
Published on September 24, 2012 Thyrogen (rhTSH), used in connection with testing and treatment of differentiated thyroid cancer (papillary, follicular, and their variants) Speaker: Bryan R. Haugen, M.D., Endocrinologist, University of Colorado Health Science Center, Denver, Colorado. Dr. Haugen is the President-Elect of the American Thyroid Association, to become ATA President in late September 2012, and is a ThyCa Medical Advisor. Moderator: Jan Halzel, Pharm.D., ThyCa Medical Advisor Bryan R. Haugen, M.D., Endocrinologist, University of Colorado School of Medicine, is Professor of Medicine and Pathology, as well as Head, Division of Endocrinology, Metabolism & Diabetes, and Chair of Endocrine Neoplasms Research. Dr.Haugen's clinical interests include thyroid neoplasms, advanced thyroid cancer, thyroid dysfunction, and other endocrine tumors. Dr Haugen’s research interests include molecular studies of thyroid neoplasm diagnosis and pathophysiology as well as the study of molecular therapeutic targets. Specific areas of research include nuclear hormone receptors (RXR, TR, PPAR) and kinase signaling pathways as therapeutic targets in thyroid cancer, as well as proteomic approaches to molecular markers in thyroid neoplasms. His research group is also actively studying novel regulation of the hypothalamic-pituitary-thyroid axis.Dr. Haugen is President of the American Thyroid Association. He is a member of ThyCa's Medical Advisory Council. Moderator: Jan Halzel, Pharm.D. Jan Halzel, Pharm.D. works in drug safety and clinical data management in the pharmaceutical industry. She is a co-moderator of ThyCa's Medullary Thyroid Cancer E-mail Support Group and is involved in developing the Medullary Thyroid Cancer content on ThyCa's web site. She also represents ThyCa at medical association meetings. She earned her bachelor's degree in pharmacy at the University of Rhode Island and her doctoral degree at the University of Colorado Health Sciences Center. She is a member of ThyCa's Medical Advisory Council.
Living With Thyroid cancer
 
02:58
Thyroid cancer affects the thyroid gland in the body. Learn more about Thyroid cancer and what it is like to live with it in this video.
Просмотров: 7697 LIVESTRONG.COM
What does Thyroid Cancer look like?
 
00:16
Here is a short video showing my malignant tumour (Papillary Thyroid Carcinoma) before the surgeons cut it out. The tumour was 6 cm in size and as you will see in the video, not really visible until I swallowed. I am publishing the video to raise awareness of Thyroid Cancer, in the hope that other people with similar lumps on their neck, will see their doctor before it reaches this size. You can see the tumour twice in this video - once each from two different angles. There is a short delay between the two, as I found it difficult to swallow at the time. PLEASE TAKE NOTE: Having a lump similar to this DOES NOT mean you have Cancer. My mother also had a lump the same and hers was NOT Cancerous. The point is... DON'T PANIC, BUT DON'T IGNORE IT. See a doctor and find out.
Просмотров: 10705 Emma MacDonald
Breast Cancer Q&A -- Sloan-Kettering
 
44:45
Medical oncologist Larry Norton, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering, answers questions about current trends in the detection, treatment, and prevention of breast cancer.
Просмотров: 606 Memorial Sloan Kettering